An urgent need for building technical capacity for rapid diagnosis of multidrug-resistant tuberculosis (MDR-TB) among new cases: A case report from Maharashtra, India

Journal of Infection and Public Health

Volumn 8, Issue 5, 2015, Pages 502-505

  Atre, Sachin ^a  

^a UNIVERSITY OF PUNE   (India)

Author keywords

India; MDR TB; New cases; Rapid diagnosis; Technical capacity

Indexed keywords

ETHAMBUTOL PLUS ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CAPACITY BUILDING; CASE REPORT; COUGHING; FEVER; GENOTYPE; HUMAN; IMMUNOASSAY; INDIA; INFECTION CONTROL; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RAPID TEST; RECURRENT DISEASE; SHORT COURSE THERAPY; SPUTUM ANALYSIS; TERTIARY CARE CENTER; TREATMENT DURATION; WORLD HEALTH ORGANIZATION; MOLECULAR DIAGNOSIS; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; PROCEDURES; TIME FACTOR; TUBERCULOSIS, MULTIDRUG-RESISTANT;

DIAGNOSTIC SERVICES; HUMANS; INDIA; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84939269484     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2015.04.021     Document Type: Article

References (13)

1. World Health Organization Global Tuberculosis Control Report 2014 (WHO/HTM/TB/2014.08) 2014, WHO, Geneva.
2. World Health Organization Global Tuberculosis Control Report 2013 (WHO/HTM/TB/2013.13) 2013, WHO, Geneva.
3. Mitnick C., Franke M., Rich M., Alcantara V., Appleton S., Atwood S., et al. Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PLOS ONE 2013, 8(3):e58664.
4. Sharma S., Mohan A. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 2006, 130:261-272.
5. Udwadia Z., Pinto L., Uplekar M. Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades?. PLoS ONE 2010, 5(8):e12023.
6. Uplekar M., Pathania V., Raviglione M. Private practitioners and public health: weak links in tuberculosis control. Lancet 2001, 358(9285):912-916.
7. Mitnick C., Bayona J., Palacios E., Shin S., Furin J., Alcantara F., et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003, 348:119-128.
8. Central TB Division (CTD) Technical and operational guidelines for tuberculosis control 2005, Ministry of Health & Family Welfare, Nirman Bhavan, New Delhi, Available at http://tbcindia.nic.in/pdfs/Technical%20&%20Operational%20guidelines%20for%20TB%20Control.pdf [accessed 25.02.15].
9. Central TB Division (CTD) Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India 2012, Ministry of Health & Family Welfare, Nirman Bhavan, New Delhi, Available at http://www.tbcindia.nic.in/pdfs/Guidelines%20for%20PMDT%20in%20India%20-%20May%202012.pdf [accessed 05.03.14].
10. Ling D., Zwerling A., Pai M. Genotype MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 2008, 32:1165-1174.
11. Atre S.R., D'Souza D.T., Dholakia Y.N., Mistry N.F. Observations on categorization of new TB cases: implications for controlling drug resistance. Int J Tuberc Lung Dis 2007, 11:1152-1153.
12. Farmer P., Nizeye B., Stulac S., Keshavjee S. Structural violence and clinical medicine. PLoS Med 2006, 3(10):e449. 10.1371/journal.pmed.0030449.
13. World Health Organization Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF System 2011, WHO, Geneva, Available at http://whqlibdoc.who.int/publications/2011/9789241501545_eng.pdf?ua=1 [accessed 05.03.14].